Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-25
2011-01-25
Anderson, James D (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S064000
Reexamination Certificate
active
07875624
ABSTRACT:
Methods of using compounds having Structure I or the salts or tautomers of the compounds in the treatment of disorders relating to cell adhesion and metastatic processes are presented herein.
REFERENCES:
patent: 3663606 (1972-05-01), Yoshikazu
patent: 4659657 (1987-04-01), Harnisch et al.
patent: 4882342 (1989-11-01), Von der Saal et al.
patent: 5073492 (1991-12-01), Chen et al.
patent: 5151360 (1992-09-01), Handa et al.
patent: 5330992 (1994-07-01), Eissenstat et al.
patent: 5414088 (1995-05-01), Von Der Saal et al.
patent: 5480883 (1996-01-01), Spada et al.
patent: 5585380 (1996-12-01), Bianco et al.
patent: 5646153 (1997-07-01), Spada et al.
patent: 5710158 (1998-01-01), Myers et al.
patent: 5763441 (1998-06-01), App et al.
patent: 5792771 (1998-08-01), App et al.
patent: 5801212 (1998-09-01), Okamoto et al.
patent: 5855866 (1999-01-01), Thorpe et al.
patent: RE36256 (1999-07-01), Spada et al.
patent: 5942385 (1999-08-01), Hirth
patent: 5981569 (1999-11-01), App et al.
patent: 6057320 (2000-05-01), Spada et al.
patent: 6111110 (2000-08-01), Brenan et al.
patent: 6137010 (2000-10-01), Joo et al.
patent: 6174912 (2001-01-01), Beck et al.
patent: 6258951 (2001-07-01), Lohmann et al.
patent: 6268391 (2001-07-01), Dickerson et al.
patent: 6303600 (2001-10-01), Cox et al.
patent: 6306874 (2001-10-01), Fraley et al.
patent: 6313138 (2001-11-01), Fraley et al.
patent: RE37650 (2002-04-01), Myers et al.
patent: 6420382 (2002-07-01), Fraley et al.
patent: 6479512 (2002-11-01), Fraley et al.
patent: 6593344 (2003-07-01), Biedermann et al.
patent: 6605617 (2003-08-01), Renhowe et al.
patent: 6756383 (2004-06-01), Renhowe et al.
patent: 6759417 (2004-07-01), Renhowe et al.
patent: 6762194 (2004-07-01), Renhowe et al.
patent: 6774237 (2004-08-01), Renhowe et al.
patent: 6774327 (2004-08-01), Wong
patent: 6800760 (2004-10-01), Renhowe et al.
patent: 7064215 (2006-06-01), Renhowe et al.
patent: 7179912 (2007-02-01), Halbrook et al.
patent: 7470709 (2008-12-01), Barsanti et al.
patent: 2002/0103230 (2002-08-01), Renhowe et al.
patent: 2002/0107392 (2002-08-01), Renhowe et al.
patent: 2002/0165218 (2002-11-01), Halbrook et al.
patent: 2003/0028018 (2003-02-01), Renhowe et al.
patent: 2003/0087854 (2003-05-01), Monia et al.
patent: 2003/0158224 (2003-08-01), Renhowe et al.
patent: 2003/0159702 (2003-08-01), Lindell et al.
patent: 2003/0207883 (2003-11-01), Renhowe et al.
patent: 2004/0002518 (2004-01-01), Renhowe et al.
patent: 2004/0006101 (2004-01-01), Renhowe et al.
patent: 2004/0092535 (2004-05-01), Barsanti et al.
patent: 2004/0097545 (2004-05-01), Renhowe et al.
patent: 2004/0220196 (2004-11-01), Hannah et al.
patent: 2005/0054672 (2005-03-01), Renhowe et al.
patent: 2005/0137399 (2005-06-01), Cai et al.
patent: 2005/0203101 (2005-09-01), Barsanti et al.
patent: 2005/0209247 (2005-09-01), Cai et al.
patent: 2005/0256157 (2005-11-01), Gesner et al.
patent: 2005/0261307 (2005-11-01), Cai et al.
patent: 2006/0261307 (2006-11-01), Black et al.
patent: 2003290699 (2004-06-01), None
patent: 2421120 (2002-03-01), None
patent: 23463 (2003-11-01), None
patent: 2363459 (1975-06-01), None
patent: 3634066 (1988-04-01), None
patent: 19841985 (2000-03-01), None
patent: 0290153 (1988-11-01), None
patent: 0 509 717 (1992-04-01), None
patent: 0 508 800 (1992-10-01), None
patent: 0 747 771 (1996-12-01), None
patent: 0 797 376 (1997-09-01), None
patent: 0 290 153 (1998-11-01), None
patent: 1 086 705 (2001-03-01), None
patent: P0104752 (2002-07-01), None
patent: 59-130284 (1984-07-01), None
patent: 63-230687 (1988-09-01), None
patent: 02-229165 (1990-09-01), None
patent: 6-9952 (1994-01-01), None
patent: 7-43896 (1995-02-01), None
patent: 8-29973 (1996-02-01), None
patent: 63-258903 (1998-10-01), None
patent: WO 91/04974 (1991-04-01), None
patent: WO 92/18483 (1992-10-01), None
patent: WO 92/20642 (1992-11-01), None
patent: WO-94/11337 (1994-05-01), None
patent: WO 95/15758 (1995-06-01), None
patent: WO-95/18622 (1995-07-01), None
patent: WO 95/18801 (1995-07-01), None
patent: WO 97/03069 (1997-01-01), None
patent: WO-97/21436 (1997-06-01), None
patent: WO 97/34876 (1997-09-01), None
patent: WO 97/48694 (1997-12-01), None
patent: WO 98/13350 (1998-04-01), None
patent: WO 98/55124 (1998-12-01), None
patent: WO 99/10349 (1999-03-01), None
patent: WO 99/16755 (1999-04-01), None
patent: WO-99/48868 (1999-09-01), None
patent: WO 99/50263 (1999-10-01), None
patent: WO 99/65897 (1999-12-01), None
patent: WO 00/00481 (2000-01-01), None
patent: WO 00/03990 (2000-01-01), None
patent: WO 00/11709 (2000-03-01), None
patent: WO 00/20400 (2000-04-01), None
patent: WO 00/27379 (2000-05-01), None
patent: WO 00/31049 (2000-06-01), None
patent: WO 00/35492 (2000-06-01), None
patent: WO 00/58315 (2000-10-01), None
patent: WO 00/71129 (2000-11-01), None
patent: WO 00/74683 (2000-12-01), None
patent: WO 01/02369 (2001-01-01), None
patent: WO 01/12169 (2001-02-01), None
patent: WO 01/28993 (2001-04-01), None
patent: WO 01/29025 (2001-04-01), None
patent: WO 01/52875 (2001-07-01), None
patent: WO 01/52904 (2001-07-01), None
patent: WO 01/53268 (2001-07-01), None
patent: WO 01/55114 (2001-08-01), None
patent: WO 01/62251 (2001-08-01), None
patent: WO 01/62252 (2001-08-01), None
patent: WO 01/74296 (2001-10-01), None
patent: WO 02/18383 (2002-03-01), None
patent: WO 02/22598 (2002-03-01), None
patent: WO 02/26716 (2002-04-01), None
patent: WO 02/32861 (2002-04-01), None
patent: WO 02/058697 (2002-08-01), None
patent: WO 03/004488 (2003-01-01), None
patent: WO 03/033472 (2003-04-01), None
patent: WO 03/087095 (2003-10-01), None
patent: WO 2004/018419 (2004-03-01), None
patent: WO 2004/030620 (2004-04-01), None
patent: WO 20041031401 (2004-04-01), None
patent: WO 2004/043389 (2004-05-01), None
patent: WO 2004/063151 (2004-07-01), None
patent: WO 2004/063170 (2004-07-01), None
patent: WO-2004/073631 (2004-09-01), None
patent: WO 2004/087153 (2004-10-01), None
patent: WO-2004/103274 (2004-12-01), None
patent: WO 2005/009967 (2005-02-01), None
patent: WO-2005/037306 (2005-04-01), None
patent: WO 2005/046589 (2005-05-01), None
patent: WO 2005/046590 (2005-05-01), None
patent: WO 2005/047244 (2005-05-01), None
patent: WO 2005/053692 (2005-06-01), None
patent: WO 2005/082340 (2005-09-01), None
patent: WO 2006/081445 (2006-08-01), None
patent: WO 2006/27926 (2006-11-01), None
Yoo et al., Synchronous Elevation of Soluble Intercellular Adhesion Molecule-1 (ICAM-1) and Vascular Cell Adhesion Molecule-1 (VCAM-1) Correlates with Gastric Cancer Progression, 1998, Yonsei Medical Journal, vol. 39. No. 1, pp. 27-36.
Blakey et al., Anti-cancer drug discovery and development summit, 2003, Expert Opin. Investig. Drugs, vol. 12, No. 9, pp. 1577-1582.
Gontero, et al., “Metastasis Markers in Bladder Cancer: A Review of the Literature and Clinical Considerations”, European Urology, vol. 46, pp. 296-311 (2004).
Kirstein, Ca 145:201781, abstract only of Recent Patents on Anti-cancer Drug Discovery, vol. 1(2), pp. 153-161 (2006).
Grand, et al., Targeting FGFR3 in Multiple Myeloma: Inhibition of t(4;14) Positive Cells by SU5402 and PD173074, Leukemia, 2004, vol. 18, pp. 962-966.
Dalton, et al., “Multiple Myeloma,” Hematology, Am. Soc. Hematol. Educ. Program, 2001, 157-77.
Ukrainets, et al., “Effective Synthesis of 3-(Benzimidazol-2-yl)-4-Hydroxy-2-Oxo-1,2-Dihydroquinolines,” Tetrahedron Letters, vol. 36, No. 42, 1995, pp. 7747-7748.
Carla Heise, et al., “In vivo Preclinical Evaluation of Tyrosine Kinase Inhibitors with Potent Effects on Tumor Angiogenesis, Growth and Metastasis,” Abstract and presentation material for a presentation at the American Association for Cancer Research meeting held in Apr. 2002.
U.S. Appl. No. 10/644,055, filed Aug. 2003, Barsanti, et al.
U.S. Appl. No. 10/839,793, filed May 2004, Barsanti, et al.
U.S. Appl. No. 10/982,543, filed Nov. 2004, Cai, et al.
Cecil, Textbook of Medicine, 21stEdition (2000), Goldman & Bennett (Editors), W.B. Saunders Company (Publisher), Chapter 198, pp. 1060-1074.
Ukrainets et al., “Effective Synthesis of 3-(Benzimidazol-2-yl)-4-Hydroxy-
Heise Carla
Lee Sang H.
Anderson James D
Finn Meghan
Foley & Lardner LLP
Novartis Vaccines and Diagnostics Inc.
LandOfFree
Modulating and measuring cellular adhesion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulating and measuring cellular adhesion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulating and measuring cellular adhesion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2700665